CDKN2A and central nervous system cancer: ACT Genomics Co. Ltd. (Hong Kong) offers a RUO ACTOnco + kit that covers 440 genes with the glioma-related ones (IDH1, IDH2, BRAF, CDKN2A, CDKN2B, CIC, FUBP1, NOTCH1, etc.)for solid tumor molecular profiling compatible with the Ion Torrent platform (Jan et al., 2022).